Menopause Therapy_ New FDA Guidance

FDA Removes More Black Box Warnings From Menopause Hormone Therapy

October 30, 2026 Women navigating menopause have another reason to take a closer look at their treatment options. The U.S. Food and Drug Administration (FDA) has approved updated labeling for three additional menopausal hormone therapy products, removing several long-standing risk statements from their prominent black box warnings. Announced October 30 by the U.S. Department of

FDA Removes More Black Box Warnings From Menopause Hormone Therapy Read More »